α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1635-1640

  Martin Ruiz, C M ^a   Court, J A ^a   Molnar, E ^b   Lee, M ^a   Gotti, C ^c   Mamalaki, A ^d   Tsouloufis, T ^d   Tzartos, S ^d   Ballard, C ^a   Perry, R H ^a   Perry, E K ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c CNR   (Italy)

^d HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

3 subunit; 4 subunit; 7 subunit; Alzheimer's disease; Nicotinic acetylcholine receptors; Tobacco smoking

Indexed keywords

EPIBATIDINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; ALPHA-BUNGAROTOXIN RECEPTOR; ANTIBODY; BUNGAROTOXIN RECEPTOR; CHRNA3 PROTEIN, HUMAN; CHRNA3 PROTEIN, MOUSE; FUSED HETEROCYCLIC RINGS; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA4 SUBUNIT; NICOTINIC AGENT; PYRIDINE DERIVATIVE; TRITIUM;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SMOKING; TEMPORAL CORTEX; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; IMMUNOBLOTTING; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NEUROBLASTOMA; PATHOLOGY; RADIOASSAY; REFERENCE VALUE; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BICYCLO COMPOUNDS, HETEROCYCLIC; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MICE; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; NICOTINIC AGONISTS; PYRIDINES; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; REFERENCE VALUES; TEMPORAL LOBE; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0032589299     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731635.x     Document Type: Article

References (38)

1. 3H]nicotine binding sites in human brain. J. Neurochem. 50, 1243-1247.
2. Chen Y., Ogren S., Bjelke B., Bolme P., Eneroth P., Gross J., Lodl F., Henera-Marschitz M., and Andersson K. (1995) Nicotine treatment counteracts perinatal asphyxia-induced changes in mesostriatal/limbic dopamine systems and in motor behaviour in the four-week old male rat. Neuroscience 68, 531-538.
3. Court J. A. and Perry E. K. (1995) Distribution of nicotinic receptors in the CNS, in CNS Neurotransmitters and Neuromodulators (Stone T. W., ed), pp. 85-104. CRC Press, London.
4. Davies P. and Feisullin S. (1981) Postmortem stability of α-bungarotoxin binding sites in mouse and human brain. Brain Res. 216, 449-454.
5. Elliott J. K., Ellis S. B., Berckhan K. J., Urrutia A., Chavez-Noriega L. E., Johnson E. C., Veliçelebi G., and Harpold M. M. (1996) Comparative structure of human neuronal α2-α7 and β2-β4 nicotinic acetylcholine receptor subunits and functional expression of the α2, α3, α4, α7, β2 and β4 subunits. J. Mol. Neurosci. 7, 217-228.
6. Eseri M. (1994) Dementia and normal aging: neuropathology, in Dementia and Normal Aging (Huppert F., Brayne C., and O'Connor D., eds), pp. 385-436. Cambridge University Press, Cambridge.
7. Flores C. M., Rogers S. W., Pabreza L. A., Wolfe B. B., and Kellar K. J. (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31-37.
8. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., and Lindstrom J. (1995) Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic receptors. Mol. Pharmacol. 48, 774-782.
9. Gotti C., Briscini L., Verderio C., Oortgiesen M., Balestra B., and Clementi F. (1995) Native nicotinic acetylcholine receptors in human Imr32 neuroblastoma cells: functional, immunological and pharmacological properties. Eur. J. Neurosci. 7, 2083-2092.
10. 3H]epibatidine binding to nicotinic cholinergic receptors in the rat and human brain. Mol. Pharmacol. 48, 280-287.
11. Hsu Y.-N., Amin J., Weiss D. S., and Wecker L. (1996) Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66, 667-675.
12. Hsu Y.-N., Edwards S. C., and Wecker L. (1997) Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of α4 subunits of neuronal nicotinic receptors. J. Neurochem. 69, 2427-2431.
13. Hucho F., Tsetlin V. I., and Machold J. (1996) The emerging three-dimensional structure of a nicotinic acetylcholine receptor. Eur. J. Biochem. 239, 539-557.
14. Janson A. M., Fuxe K., Agnati L. F., Bjelke B., Sundstrom E., Andersson K., Harfstand A., Goldstein M., and Owman C. (1989) Protective effects of chronic nicotine treatment on lesioned dopamine neurons in the male rat. Prog. Brain Res. 79, 257-265.
15. Jones G., Sahakian B., Levy R., Warburton D., and Gray J. (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl.) 108, 485-494.
16. Lindstrom J., Schoepfer R., Conroy W., Whiting P., Das M., Saedi M., and Anand R. (1991) The nicotinic acetylcholine receptor gene family: structure of nicotinic receptors from muscle and neurons and neuronal α-bungarotoxin-binding proteins. Adv. Exp. Med. Biol. 287, 255-278.
17. Lindstrom J., Anand R., Peng X., Gerzanich V., Wang F. and Li Y. (1995) Neuronal nicotinic receptor subtypes. Ann. NY Acad. Sci. 757, 100-116.
18. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 153, 265-275.
19. Lukas R. J., Norman S. A., and Lucero L. (1993) Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y neuroblastoma clonal cell line. Mol. Cell Neurosci. 4, 1-12.
20. Marks M. J., Pauly J. R., Gross S. D., Deneris E. S., Hermans-Borgmeyer I., Heinemann S. F., and Collins A. C. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12, 2765-2784.
21. 3H]epibatidine. Brain Res. 801, 143-149.
22. McGehee D. S. and Role L. W. (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57, 521-546.
23. 11C-nicotine binding in normal and Alzheimer brains - in vivo assessment using positron emission tomography. Alzheimer Dis. Assoc. Disord. 9, 21-27.
24. Olale F., Gerzanich V., Kuryatov A., Wang F., and Lindstrom J. (1997) Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283, 675-683.
25. Parks R., Becker R., Rippey R., Gilbert D., Matthews J., Kabatay E., Young C., Vohs C., Danz V., Keim P., Collins G., Zigler S., and Urycki P. (1996) Increased regional cerebral glucose metabolism and sematic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study. Neuropsychol. Rev. 6, 61-79.
26. Rogers S., Gahring L., Collins A., and Marks M. (1998) Age-related changes in neuronal nicotinic acetylcholine receptor subunit α4 expression are modified by long-term nicotine administration. J. Neurosci. 18, 4825-4832.
27. Sabbagh M. N., Reid R. T., Corey-Bloom J., Rao T. S., Hansen L. A., Alford M., Masliah E., Adem A., Lloyd G. K., and Thal L. J. (1998) Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. J. Neural Transm. 105, 709-717.
28. Schröder H. and Wevers A. (1998) Nicotinic acetylcholine receptors in Alzheimer's disease. Alzheimer Dis. Rev. 3, 20-27.
29. Shimohama S., Akaike A., and Kimura J. (1996) Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann. NY Acad. Sci. 777, 356-361.
30. Socci D. and Arendash G. (1996) Chronic nicotine treatment prevents neuronal loss in neocortex resulting from nucleus basalis lesions in young adult and aged rats. Mol. Chem. Neuropathol. 27, 285-305.
31. Sparks D. L., Beach T. G., and Lukas R. J. (1998) Immunohistochemical localization of nicotinic β2 and α4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations. Neurosci. Lett. 256, 151-154.
32. Sugaya K., Giacobini E., and Chiappinelli V. A. (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J. Neurosci. Res. 27, 349-359.
33. Terzano S., Court J., Fornasari D., Griffiths M., Spurden D., Lloyd S., Perry E., and Clementi F. (1998) Expression of the α3 nicotinic receptor subunit mRNA in human brain in aging and Alzheimer's disease. Mol. Brain Res. 63, 72-78.
34. Warpman U. and Nordberg A. (1995) Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. Neuroreport 6, 2419-2423.
35. Whiting P. and Lindstrom J. (1987) Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. USA 84, 595-599.
36. Wonnacott S. (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci. 20, 92-98.
37. Zamani M., Allen Y., Owen G., and Gray J. (1997) Nicotine modulates the neurotoxic effect of beta-amyloid protein (25-35) in hippocampal cultures. Neuroreport 8, 513-517.
38. Zoli M., Lena C., Picciotto M. R., and Changeux J.-P. (1998) Identification of four classes of brain nicotinic receptors using beta2 mutant mouse. J. Neurosci. 18, 4461-4472.